| Original language | American English |
|---|---|
| State | Published - Aug 6 2022 |
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Keynote B36: Open-label study of first-line tumor treating fields (150kHz) plus pembrolizumab for non-small cell lung cancer
Research output: Contribution to conference › Presentation